If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDowning Renewa. Regulatory News (DORE)

  • This share is currently suspended. It was suspended at a price of 102.00
  • There is currently no data for DORE

Form8.3DOWNINGRENEWABLES&INFRASTRUCTURETRUSTPLC/FU

13 Oct 2025 14:54

RNS Number : 1440D
Barclays PLC
13 October 2025
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DOWNING RENEWABLES & INFRASTRUCTURE TRUST PLC/FUND

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

10 Oct 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

4,321,224

2.54%

263

0.00%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

0

0.00%

4,321,223

2.54%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

4,321,224

2.54%

4,321,486

2.54%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1p ordinary

Purchase

718

1.0200 GBP

1p ordinary

Purchase

484

1.0203 GBP

1p ordinary

Purchase

202

1.0221 GBP

1p ordinary

Purchase

3

1.0250 GBP

1p ordinary

Sale

718

1.0200 GBP

1p ordinary

Sale

283

1.0224 GBP

1p ordinary

Sale

3

1.0250 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1p ordinary

SWAP

Decreasing Short

3

1.0216 GBP

1p ordinary

SWAP

Decreasing Short

2

1.0225 GBP

1p ordinary

SWAP

Decreasing Short

1

1.0250 GBP

1p ordinary

CFD

Decreasing Short

283

1.0224 GBP

1p ordinary

CFD

Increasing Short

484

1.0203 GBP

1p ordinary

CFD

Increasing Short

231

1.0224 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

13 Oct 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETPKNBDBBDDCKD
Date   Source Headline
1st Aug 202311:02 amRNSTotal Voting Rights
31st Jul 20233:50 pmRNSTransaction in Own Shares
24th Jul 20233:48 pmRNSDirector/PDMR Shareholding
19th Jul 20236:05 pmRNSDirector/PDMR Shareholding
14th Jul 202310:26 amRNSTransaction in Own Shares
13th Jul 20237:00 amRNSAcquisition of Swedish Electricity Distributor
7th Jul 20233:01 pmRNSTransaction in Own Shares
3rd Jul 20234:33 pmRNSTransaction in Own Shares
3rd Jul 202310:50 amRNSTotal Voting Rights
30th Jun 20236:16 pmRNSTransaction in Own Shares
29th Jun 20236:16 pmRNSTransaction in Own Shares
26th Jun 20235:35 pmRNSTransaction in Own Shares
22nd Jun 20235:45 pmRNSTransaction in Own Shares
21st Jun 20236:07 pmRNSTransaction in Own Shares
19th Jun 20236:07 pmRNSTransaction in Own Shares
19th Jun 20237:00 amRNSAcquisition of Mersey Reactive Power
16th Jun 20235:34 pmRNSTransaction in Own Shares
15th Jun 20235:45 pmRNSTransaction in Own Shares
14th Jun 20235:21 pmRNSTransaction in Own Shares
8th Jun 20233:43 pmRNSResult of AGM
7th Jun 20235:25 pmRNSTransaction in Own Shares
6th Jun 202312:53 pmRNSTransaction in Own Shares
1st Jun 202311:38 amRNSTotal Voting Rights
31st May 20235:40 pmRNSTransaction in Own Shares
30th May 20237:00 amRNSNet Asset Value and Operational Update
26th May 20234:46 pmRNSTransaction in Own Shares
23rd May 20237:00 amRNSDividend Declaration
5th May 20235:37 pmRNSTransaction in Own Shares
2nd May 20234:36 pmRNSTotal Voting Rights
27th Apr 20235:51 pmRNSTransaction in Own Shares
27th Apr 20237:00 amRNSReconfirmation of Expected Dividend Cover
27th Apr 20237:00 amRNSAcquisition of UK Solar Assets
26th Apr 20236:03 pmRNSTransaction in Own Shares
25th Apr 20235:41 pmRNSTransaction in Own Shares
18th Apr 20231:35 pmRNSPublication of Supplementary Prospectus
5th Apr 20237:00 amRNSPublication of Notice of AGM
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20235:38 pmRNSTransaction in Own Shares
29th Mar 20234:05 pmRNSNotice of Results
24th Mar 20236:09 pmRNSTransaction in Own Shares
24th Mar 20237:00 amRNSShare Buybacks
16th Mar 20237:00 amRNSNet Asset Value update
2nd Mar 20237:00 amRNSAcquisition of Two Hydropower Plants
2nd Mar 20237:00 amRNSDividend target increase
23rd Feb 20237:00 amRNSDividend Declaration
26th Jan 20237:00 amRNSIncrease of Revolving Credit Facility
11th Jan 202311:42 amRNSHolding(s) in Company
24th Nov 20227:00 amRNSNet Asset Value, Operational and Deployment Update
24th Nov 20227:00 amRNSDividend Declaration
21st Nov 20225:47 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.